Michael K. Schultz

212Pb-Pretargeted Theranostics for Pancreatic Cancer

S. Monette, David Bauer, S. Kaminsky, 2023, The Journal of Nuclear Medicine.

Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy

D. Zepeda-Orozco, Dongyoul Lee, Frances L. Johnson, 2023, European journal of nuclear medicine and molecular imaging.

Pre-clinical Evaluation of Biomarkers for Early Detection of Nephrotoxicity Following Alpha-particle Radioligand Therapy

D. Zepeda-Orozco, Dongyoul Lee, Frances L. Johnson, 2023, bioRxiv.